Tiamenidine

This classification denotes an alpha-adrenergic agonist with the molecular formula C8H10ClN3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 195V08O55G, chemically known as 2-imidazoline, 2-((2-chloro-4-methyl-3-thienyl)amino)-, monohydrochloride but generally known as tiamenidine, which bears US NIH Compound Identifier 39973. European Medicines Agency schedules Tiamenidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11001MIG. The term TIAMENIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). TIAMENIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tiamenidine under HS 29349990 and SITC 51579. As of Q4 2014, TIAMENIDINE remains the US FDA Preferred Term for this commodity. Tiamenidine bears US NLM identifiers UMLS ID C0076650 and NCI Concept Code C75046. SMILES: CLC1SCC(C1NC1=NCCN1)C.CL.